Delivery Order SPE2DB22D1202-SPE2DB25FVKU7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,994.33 to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (90-count) on August 22, 2025, with a completion date of August 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a pharmaceutical supply delivery under the Defense Logistics Agency's...
- The Defense Logistics Agency awarded a $1,436.96 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Terbinafine HCL 250 mg tablets (90-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of July 22, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $5,056.95 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (30-count units). The contract is a firm fixed price delivery order with an ultimate completion date of September 4, 2025, and was awarded on September 3, 2025. This non-set-aside award was competitively awarded, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $3,385.05 to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Terbinafine HCl 250 mg tablets (90-count). This competitive award, issued without set-aside designation, is structured as a firm fixed-price delivery order with a completion deadline of September 4, 2025. AmerisourceBergen Drug Corp will perform the work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Terbinafine HCL 250 mg tablets (90-count) with a ceiling value of $3,690.52. This competitive contract, issued under a firm fixed-price delivery order structure, represents a child order against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30, with a ceiling value of $5,072.07. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award to the vendor based on standard federal procurement practices. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, and the order is scheduled...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Terbinafine HCL 250 mg tablets (100-count) with a contract value of $2,205.41. This is a firm fixed-price delivery order with an ultimate completion date of July 25, 2025, and represents a non-competitive set-aside award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,834.25 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Terbinafine HCL 250 mg tablets in 30-count units. This is a firm fixed price delivery order with an ultimate completion date of September 3, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award utilized no set-aside designation, indicating the contract was competitively awarded through open...
- The Defense Logistics Agency awarded a delivery order valued at $1,255.57 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets in quantities of 30. The contract, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, utilizes firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is the prime contractor on this delivery order, which...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Terbinafine HCL 250 mg tablets in 30-count packages, with a ceiling value of $1,013.59. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVKU7Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for Terbinafine HCL 250 mg tablets (90-count supply) valued at $4,586.12. This firm fixed-price delivery order, with an ultimate completion date of September 10, 2025, represents a non-competitive set-aside award for pharmaceutical supply to support federal medical procurement needs. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. That prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates extensive capability in delivering diverse pharmaceutical products across multiple therapeutic domains to military and veteran healthcare systems, positioning the company as a critical vendor within the Defense Logistics Agency's Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 9/9/25 |